These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 7214362

  • 1. Arrest of in vivo proliferation of Zajdela tumor cells by inhibition of mitochondrial protein synthesis.
    van den Bogert C, Dontje BH, Wybenga JJ, Kroon AM.
    Cancer Res; 1981 May; 41(5):1943-7. PubMed ID: 7214362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Arrest of in vivo growth of a solid Leydig cell tumor by prolonged inhibition of mitochondrial protein synthesis.
    van den Bogert C, Dontje BH, Kroon AM.
    Cancer Res; 1983 May; 43(5):2247-51. PubMed ID: 6831447
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of long-term inhibition of mitochondrial protein synthesis on the oxidation capacity of mitochondria for NADH-linked substrates.
    Kroon AM, Holtrop M, Fries H, Melis T, van den Bogert C.
    Biochem Biophys Res Commun; 1985 May 16; 128(3):1190-5. PubMed ID: 3924042
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
    Hribaschek A, Meyer F, Schneider-Stock R, Pross M, Ridwelski K, Lippert H.
    Chemotherapy; 2007 May 16; 53(6):410-7. PubMed ID: 17952000
    [Abstract] [Full Text] [Related]

  • 13. Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells.
    Aizencang G, Harari P, Buldain G, Guerra L, Pickart M, Hernandez P, Frydman B.
    Cell Mol Biol (Noisy-le-grand); 1998 Jun 16; 44(4):615-25. PubMed ID: 9678897
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells.
    Pang LP, Huang W, Sun Q, Guo W, Li RT, Cui JR.
    Anticancer Drugs; 2008 Feb 16; 19(2):167-74. PubMed ID: 18176113
    [Abstract] [Full Text] [Related]

  • 20. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H, Takahashi S, Imamura M, Okutani E, Zhang ZG, Chayama K, Chen BA.
    Chin Med J (Engl); 2007 May 20; 120(10):898-904. PubMed ID: 17543180
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.